Related Experiment Video
Updated: Jun 20, 2026

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative
Bonnie O Wong1,2,3, Orly N Farber1,2, Amanda J Reich2
1Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Traditional cancer surgery terms "curative" or "palliative" are insufficient. A new "disease-control" surgery category better reflects modern cancer care, focusing on patient-specific treatment goals within a multidisciplinary approach.
Area of Science:
- Oncology
- Surgical Oncology
- Cancer Research
Background:
- Evolving cancer biology and treatments are changing cancer into a chronic disease.
- Surgery's role is shifting beyond purely curative or palliative intent.
- Existing terminology struggles to encompass new surgical applications.
Purpose of the Study:
- To explore the inadequacy of traditional surgical intent categories.
- To introduce and define "disease-control" surgery.
- To align surgical terminology with contemporary cancer care.
Main Methods:
- Semi-structured interviews with 18 cancer surgeons from 16 US institutions.
- Purposive snowball sampling for participant recruitment.
- Thematic analysis of interview data exploring hypothetical scenarios.
Main Results:
- Surgeons recognize limitations in "curative" vs. "palliative" language.
- "Disease-control" surgery encompasses debulking, resecting resistant disease, and managing indolent tumors.
- Surgical goals are increasingly integrated into broader patient treatment plans.
Conclusions:
- Current surgical intent categories are inadequate for modern cancer surgery.
- A "disease-control" framework may improve communication and research.
- Standardized terminology requires multidisciplinary validation.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
